Early recognition of neonatal hyperbilirubinemia and its emergent management

Seminars in Fetal and Neonatal Medicine

Volumn 11, Issue 3, 2006, Pages 214-224

  Smitherman, Hannah ^a   Stark, Ann R ^a   Bhutan, Vinod K ^b  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b STANFORD UNIVERSITY   (United States)

Author keywords

Acute bilirubin encephalopathy; Bilirubin induced neurologic dysfunction; Neonatal emergencies; Neonatal hyperbilirubinemia; Newborn jaundice

Indexed keywords

HEME OXYGENASE INHIBITOR; IMMUNOGLOBULIN; LATAMOXEF; SALICYLIC ACID; SULFAFURAZOLE; SULFONAMIDE;

ANAMNESIS; ARTICLE; BIRTH; BREAST FEEDING; CLINICAL TRIAL; COST CONTROL; COST EFFECTIVENESS ANALYSIS; DISEASE COURSE; EMBOLISM; EMERGENCY CARE; EMERGENCY WARD; EVALUATION; EXCHANGE BLOOD TRANSFUSION; FOLLOW UP; HEALTH CARE ACCESS; HEART ARRHYTHMIA; HOSPITAL DISCHARGE; HUMAN; INCIDENCE; KERNICTERUS; NECROTIZING ENTEROCOLITIS; NEUROLOGIC DISEASE; NEWBORN JAUNDICE; NEWBORN MONITORING; OUTPATIENT CARE; PATHOPHYSIOLOGY; PERINATAL PERIOD; PHOTOTHERAPY; PREVALENCE; SEPSIS; SYMPTOMATOLOGY; THROMBOCYTOPENIA; UNITED STATES;

BILIRUBIN; EMERGENCY MEDICAL SERVICES; GUIDELINES; HUMANS; HYPERBILIRUBINEMIA, NEONATAL; INFANT; INFANT, NEWBORN; KERNICTERUS; RISK FACTORS;

EID: 33646103910     PISSN: 1744165X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.siny.2006.02.002     Document Type: Article

References (56)

1. Bhutani V.K., Johnson L.H., and Shaprio S.M. Kernicterus in sick and preterm infants (1999-2002): a need for an effective preventive approach. Semin Perinatol 28 5 (October 2004) 3129-5 [Review]
2. Centers for Disease Control and Prevention. National center on birth defects and developmental disabilities: kernicterus. October 24, 2002. Available at http://www.cdc.gov/ncbddd/dd/kernicterus2.htm.
3. Brown A.K., and Johnson L. Loss of concern about jaundice and the reemergence of Kernicterus in full-term infants in the era of managed care. In: Fanaroff A.A., and Klaus M.H. (Eds). The year book of neonatal and perinatal medicine (1996), Mosby Yearbook, Philadelphia xvii-xxviii
4. A National Framework for Healthcare Quality Measurement and Reporting: A Consensus Report. National Quality Forum http://www.qualityforum.org.
5. Maisels M.J., and Gifford K.L. Normal serum bilirubin level in the newborn and the effect of breastfeeding. Pediatrics 78 (1986) 837-843
6. American Academy of Pediatrics Practice Guidelines. Subcommittee on Hyperbilirubinemia. Management of hyperbilirubinemia in the newborn infant 35 weeks or more of gestation. Pediatrics 114 1 (2004) 297-316
7. American Academy of Pediatrics Practice Parameter. Management of hyperbilirubinemia in the healthy term newborns. Pediatrics 94 (1994) 558-565
8. Mollen T.J., Scarfone R., and Harris M.C. Acute severe bilirubin encephalopathy in a newborn. Pediatric Emergency Care 20 90 (September 2004) 599-601
9. Bhutani V.K., Johnson L., and Sivieri E.M. Predictive ability of pre-discharge hour-specific bilirubin for subsequent significant hyperbilirubinemia in healthy term and near-term newborns. Pediatrics 103 (1999) 6-14
10. Stevenson D.K., Fanaroff A., Maisels J., et al. Prediction of hyperbilirubinemia in term and near-term newborn infants. Pediatrics 108 (2001) 31-39
11. Bhutani V.K., Johnson L.H., and Keren R. Diagnosis and management of hyperbilirubinemia in the term neonate: for a safer first week. Pediatr Clin North Am 51 4 (August 2004) 843-861 vii
12. Bhutani V.K., Johnson L.H., Maisels M.J., et al. Kernicterus: epidemiological strategies for its prevention through systems-based approaches. J Perinatol 24 10 (2004) 650
13. Bhutani V.K., Johnson L.H., and Koren R. Treating acute bilirubin encephalopathy-before its too late. Contemp Pedso 22 (2005) 57
14. Kaplan M., Hercshel M., Hammerman C., Hoyer J.D., and Stevenson D.K. Hyperbilirubinemia among African American, glucose-6-phosphate dehydrogenase deficient neonates. Pediatrics 114 2 (August 2004) e213-e219
15. Poland R.L. Preventing kernicterus: almost there. J Pediatr 140 4 (April 2002) 396-403
16. Bhutani V.K. Neonatal hyperbilirubinemia and the potential risk of subtle neurological dysfunction. Pediatr Res 50 (2001) 679
17. Nakamura H., Yonetani M., Uetani Y., Funato M., and Lee Y. Determination of serum unbound bilirubin for prediction of kernicterus in low birth weight infants. Acta Paediatr Jpn 34 (1992) 642-647
18. Funato M., Teraoka S., Tamai H., Shimada S., and Nakamura H. Follow-up study of auditory brainstem evoked responses in hyperbilirubinemic newborns treated with exchange transfusion. Acta Paediatr Jpn 38 (1996) 17-21
19. Ahlfors C.E. Criteria for exchange transfusion in jaundiced newborns. J Pediatr 93 (1994) 488-494
20. Mollison P.L., and Cutbush M. Diagnosis and treatment of hemolytic disease in the newborn. Concours Med 75 16 (18 April 1953) 1445
21. Jones M.H., Sands R., Hyman C.B., Sturgeon P., and Koch F.P. Longitudinal study of the incidence of central nervous system damage following erythroblastosis fetalis. Pediatrics 14 (1954) 346
22. Van Pragh R. Diagnosis of kernicterus in the neonatal period. Pediatrics 28 (1961) 870-874
23. Volpe J.J. Bilirubin and brain injury. Neurology of the newborn. 4th ed. (2001), WB Saunders, Philadelphia
24. Johnson L., Brown A.K., and Bhutani V.K. System-based approach to management of neonatal jaundice and prevention of kernicterus. J Pediatr 93 (2002) 488-494
25. Johnson L., Brown A.K., and Bhutani V.K. BIND - a clinical score for bilirubin induced neurologic dysfunction in newborns. Pediatrics Suppl 104 (1999) 746
26. Perlstein M. Neurologic sequelae of erythroblastosis fetalis. Am J Dis Child 79 (1950) 605-606
27. Soorani-Lunsing I., Woltil A., and Hadders-Algra M. Are moderate degrees of hyperbilirubinemia in healthy term neonates really safe for the brain?. Pediatr Res 50 (2001) 701-705
28. Forrester R.M., and Miller J. The dental changes associates with kernicterus. Arch Dis Child 30 (1953) 224-231
29. Byers R.K., Paine R.S., and Crothers B. Extra pyramidal cerebral palsy with hearing loss following erythroblastosis. Pediatrics 15 (1955) 248-254
30. Ohlsson A, editor. Neonatal jaundice: continuing concern and need for research. Pediatr Res 2001;50:674.
31. Maisels M.D., and Newman T.B. Bilirubin and neurologic dysfunction - do we need to change what we are doing?. Pediatr Res 50 (2001) 677
32. Hintz S., and Stevenson D.K. Just when you thought is was safe. Pediatr Res 50 (2001) 675-676
33. Joint Commission on Accreditation of Healthcare Organizations. Sentinel Event Alert 18: Kernicterus Threatens Healthy Newborns; May 2, 2001. .
34. AAP Subcommittee on Neonatal Hyperbilirubinemia. Neonatal jaundice and kernicterus. Pediatrics 108 (2001) 763-765
35. Bhutani V.K., Gourley G., Kreamer B.L., Dalin C., Adler S.A., and Johnson L. Non-invasive measurement of total serum bilirubin in a multi-racial pre-discharge newborn population to assess the risk of severe hyperbilirubinemia. Pediatrics 106 2 (2000) e17
36. Rubaltelli F.F., Gourley G.R., Loskamp N., et al. Transcutaneous bilirubin measurement: a multicenter evaluation of a new device. Pediatrics 107 (2001) 1264-1271
37. Ebbeson F., Rasmussen L.M., and Wimberly P.D. A new transcutaneous bilirubinometer, Bilichek, used in the neonatal intensive care unit and the maternity ward. Acta Paediatr 91 (2002) 203-211
38. Slusher T.M., Angyo I.A., Bode-Thomas F., Akor F., Pam S.D., Adetunii A.A., et al. Transcutaneous bilirubin measurements and serum total bilirubin levels in indigenous African infants. Pediatrics 113 6 (June 2004) 1636-1641
39. Engle W.D., Jackson G.L., Sendelbach D., Manning D., and Frawley W.H. Assessment of a transcutaneous device in the evaluation of neonatal hyperbilirubinemia in a primarily Hispanic population. Pediatrics 110 (2002) 61-67
40. Bhutani V.K., Gourley G.R., Adler S., Kreamer B., Dalin C., and Johnson L.H. Noninvasive measurement of total serum bilirubin in a multiracial predischarge newborn population to assess the risk of severe hyperbilirubinemia. Pediatrics 106 (2000) E17
41. Johnson L., and Bhutani V.K. Guidelines for management of the jaundiced term and near-term infant. Clin Perinatol 25 3 (September 1998) 555-574
42. Bhutani V.K., and Johnson L.H. Jaundice technologies: prediction of hyperbilirubinemia in term and near-term newborns. J Perinatal 21 Suppl. 1 (2001) S76-S82
43. Bhutani V.K., Johnson L., and Sivieri E.M. Predictive ability of a pre-discharge hour-specific serum bilirubin for subsequent significant hyperbilirubinemia in healthy term and near-term newborns. Pediatrics 103 1 (January 1999) 6-14
44. Bhutani V.K., and Johnson L.H. Jaundice technologies: prediction of hyperbilirubinemia in term and near-term newborns. J Perinatol 21 (2001) S76-S82
45. Garland J.S., Alex C., Deacon J.S., and Raab K. Treatment of infants with indirect Hyperbilirubinemia. Readmission to birth hospital vs nonbirth hospital. Arch Pediatr Adolesc Med 148 12 (1994) 13107-13121
46. Brown A.K., Damus K., Kim M.H., King K., et al. Factors relating to readmission of term and near-term neonates in the first two weeks of life. Early Discharge Survey Group of the Health Professional Advisory Board of the Greater New York Chapter of the March of Dimes. J Perinat Med 27 4 (1999) 263-275
47. Suresh G.K., and Clark R.E. Cost effectiveness of strategies that are intended to prevent kernicterus in newborn infants. Pediatrics 114 4 (2004) 917-924
48. Gourley G.R., Kreamer B., Cohnen M., and Kosorok M.R. Neonatal jaundice and diet. Arch Pediatr Adolesc Med 153 2 (February 1999) 184-188
49. Hansen T.W.R. Acute management of extreme neonatal jaundice - the potential benefits of intensified phototherapy and interruption of enterohepatic circulation. Acta Pediatr 86 (1997) 843-846
50. Johnson L.H., Dalin C., Abbasi S., Weis C., Gerdes J.S., and Bhutani V.K. The importance of measuring serum albumin in excessively hyperbilirubinemic infants. Pediatr Res 47 (2000) 404A
51. Alcock G.S., and Liley H. Immunoglobulin infusion for isoimmune haemolytic jaundice in neonates. Cochrane Database Syst Rev 3 (2002) CD003313
52. Bhutani V.K., Johnson L., and Sivieri E.M. Predictive ability of a pre-discharge hour-specific serum bilirubin for subsequent significant hyperbilirubinemia in healthy term and near-term newborns. Pediatrics 103 1 (January 1999) 6-14
53. Stevenson D.K., Fanaroff A., Maisels J., et al. Prediction of hyperbilirubinemia in term and near-term newborn infants. Pediatrics 108 (2001) 31-39
54. Martinez J.C., Garcia H.O., Otheguy L.E., Drummond G.S., and Kappas A. Control of severe hyperbilirubinemia in full-term newborns with the inhibitor of bilirubin production Sn-mesoporphyrin. Pediatrics 103 1 (January 1999) 1-5
55. Newman T.B., Xiong B., Gonzales V.M., and Escobar G.J. Prediction and prevention of extreme neonatal hyperbilirubinemia in a mature health maintenance organization. Arch Pediatr Adolesc Med 154 (2000) 1140-1147
56. Newman T.B., and Klebanoff M. Neonatal hyperbilirubinemia and long-term outcome: Another look at the collaborative perinatal project. Pediatrics 92 (1993) 651-657